Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase Ib/II Study of XNW5004 Tablet in Combination With KEYTRUDA (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)

Next Previous
Trial Profile

A Phase Ib/II Study of XNW5004 Tablet in Combination With KEYTRUDA (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 28 Feb 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pembrolizumab (Primary) ; XNW 5004 (Primary)
  • Indications Adenocarcinoma; Bladder cancer; Head and neck cancer; Nasopharyngeal cancer; Pelvic cancer; Prostate cancer; Solid tumours; Squamous cell cancer; Urethral cancer; Urogenital cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms KEYNOTE F19
  • Sponsors Evopoint Biosciences

Most Recent Events

  • 21 Feb 2024 Status changed from not yet recruiting to recruiting.
  • 09 Nov 2023 Planned initiation date changed from 1 Sep 2023 to 1 Nov 2023.
  • 31 Aug 2023 Status changed from planning to not yet recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top